Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Immunity, Inflammation and Disease|May 6, 2017
In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4+ T cell responses protecting from airway challenge with recombinant vaccinia-gag virusLoveline N Ngu, Nadesh N Nji, Georgia E Ambada, et al.Journal of Medical Virology|June 20, 2024
Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2Giovanni Almanzar, Kimia Koosha, Tim Vogt, et al.Communications Biology|July 15, 2024
Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2Jannik T Wagner, Sandra M Müller-Schmucker, Wenjun Wang, et al.Ebiomedicine|November 10, 2024
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responsesSebastian Einhauser, Claudia Asam, Manuela Weps, et al.European Journal of Immunology|March 30, 2021
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infectionSilvia Spoerl, Anita N Kremer, Michael Aigner, et al.Frontiers in Immunology|December 30, 2022
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infectionsMohamed Ibraheem Mahmoud Ahmed, Paulina Diepers, Christian Janke, et al.Nature Communications|November 27, 2021
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunizationDennis Lapuente, Jana Fuchs, Jonas Willar, et al.Science Immunology|December 22, 2022
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccinationPascal Irrgang, Juliane Gerling, Katharina Kocher, et al.European Journal of Immunology|August 5, 2021
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunityAndreas E Kremer, Anita N Kremer, Carsten Willam, et al.Viruses|June 24, 2022
Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County-Results from a Population-Based Longitudinal Study in GermanySebastian Einhauser, David Peterhoff, Stephanie Beileke, et al.Pageof 10